RxDoctor Payments Data

Kenneth Roberts, MD

Internal Medicine · Mechanicsville, VANPI 1487620373

Payments from drug & device makers

$7,658in general payments, 2019–2025

Across 493 payments — averaging $15.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$1K
  • Amgen$847
  • AbbVie$785
  • Lilly USA, LLC$463
  • Pfizer$455
  • AstraZeneca$425
  • plus $3K from 42 others

What the payments were for

  • Food & beverage$7,634100%
  • Education$230%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,658 in reported general payments places this provider in the 90th percentile of 2,724 internal medicine providers in Virginia.

See all internal medicine providers in Virginia

Medicare billing

Part B allowed, 2024
$420,640
Medicare patients
574
Services billed
5,762

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JanuviaSitagliptin Phosphate189$191,703
EliquisApixaban147$121,264
JardianceEmpagliflozin130$101,374
OzempicSemaglutide50$55,789
FarxigaDapagliflozin Propanediol35$42,517
XareltoRivaroxaban34$31,301
Repatha SureclickEvolocumab28$25,341
EntrestoSacubitril/Valsartan24$16,033
TrulicityDulaglutide12$14,309
Trelegy ElliptaFluticasone/Umeclidin/Vilanter18$12,568
Valsartan435$11,693
VascepaIcosapent Ethyl24$11,607
Repatha SyringeEvolocumab11$11,560
SymbicortBudesonide/Formoterol Fumarate33$10,930
Lantus SolostarInsulin Glargine,hum.Rec.Anlog53$9,982

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
MerckJanuvia$183$191,703189 claims
PfizerEliquis$455$121,264147 claims
Boehringer IngelheimJardiance, Spiriva Respimat$226$110,077142 claims
Novo NordiskOzempic$1,437$55,78950 claims
AstraZenecaFarxiga, Symbicort$425$53,44768 claims
Johnson & JohnsonXarelto$193$31,30134 claims
GSKTrelegy Ellipta, Incruse Ellipta$80$16,63530 claims
NovartisEntresto$141$16,03324 claims
Lilly USA, LLCTrulicity$463$14,30912 claims
BayerKerendia$212$7,78112 claims
Amneal Pharmaceuticals LLCLevothyroxine Sodium$25$5,385608 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,724 internal medicine providers in Virginia.

Other internal medicine in Mechanicsville

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →